- Home
- INSM vs MDB Comparison
INSM vs MDB Comparison
Compare INSM & MDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INSM | MDB |
|---|---|---|
| Founded | 1988 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.2B | 30.0B |
| IPO Year | 2000 | 2017 |
Fundamental Metrics
Financial Performance| Metric | INSM | MDB |
|---|---|---|
| Price | $150.41 | $348.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 24 | 35 |
| Target Price | $192.27 | ★ $421.65 |
| AVG Volume (30 Days) | ★ 2.3M | 1.6M |
| Earning Date | 02-19-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $447,022,000.00 | ★ $2,317,123,000.00 |
| Revenue This Year | $57.54 | $22.41 |
| Revenue Next Year | $141.54 | $18.77 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 30.34 | 20.93 |
| 52 Week Low | $60.40 | $140.78 |
| 52 Week High | $212.75 | $444.72 |
Technical Indicators
Market Signals| Indicator | INSM | MDB |
|---|---|---|
| Relative Strength Index (RSI) | 38.78 | 41.83 |
| Support Level | $142.99 | $345.00 |
| Resistance Level | $152.19 | $372.80 |
| Average True Range (ATR) | 5.58 | 23.54 |
| MACD | 0.39 | -0.13 |
| Stochastic Oscillator | 34.78 | 28.19 |
Price Performance
Historical ComparisonAbout INSM Insmed Incorporated
Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.
About MDB MongoDB Inc.
Founded in 2007, MongoDB is a vendor of a document-oriented database that accelerates development processes of new applications. Enterprise customers can choose between the fully managed offering, MongoDB Atlas, or the self-managed version, MongoDB Enterprise Advanced. MongoDB is a popular tool among developers, and its free Community Server has recorded over 500 million downloads since 2009.